The estimated Net Worth of Richard Scott Struthers is at least $26.1 Milion dollars as of 8 May 2024. Richard Struthers owns over 107,448 units of Crinetics Pharmaceuticals Inc stock worth over $18,516,700 and over the last 6 years Richard sold CRNX stock worth over $7,582,778.
Richard has made over 15 trades of the Crinetics Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Richard exercised 107,448 units of CRNX stock worth $997,117 on 8 May 2024.
The largest trade Richard's ever made was exercising 200,000 units of Crinetics Pharmaceuticals Inc stock on 2 November 2023 worth over $1,856,000. On average, Richard trades about 31,180 units every 70 days since 2019. As of 8 May 2024 Richard still owns at least 364,933 units of Crinetics Pharmaceuticals Inc stock.
You can see the complete history of Richard Struthers stock trades at the bottom of the page.
Richard's mailing address filed with the SEC is C/O CRINETICS PHARMACEUTICALS, INC., 6055 LUSK BOULEVARD, SAN DIEGO, CA, 92121.
Over the last 6 years, insiders at Crinetics Pharmaceuticals Inc have traded over $52,514,606 worth of Crinetics Pharmaceuticals Inc stock and bought 3,613,259 units worth $62,800,483 . The most active insiders traders include Advisors Llcperceptive Life..., Jack Nielsen oraz Capital Viii, Llc Vivo Capi.... On average, Crinetics Pharmaceuticals Inc executives and independent directors trade stock every 20 days with the average trade being worth of $3,116,248. The most recent stock trade was executed by Stephen F. Betz on 26 August 2024, trading 3,000 units of CRNX stock currently worth $159,570.
neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.
Crinetics Pharmaceuticals Inc executives and other stock owners filed with the SEC include: